SOLARA vs VIYASH: Stock Comparison

Solara Active Pharma Sciences Limited vs Viyash Scientific Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Solara Active Pharma Sciences Limited shows a lower P/E and faster revenue growth, while Viyash Scientific Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Solara Active Pharma Sciences Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, SOLARA is more favourable on 4 of 13 scored metrics and VIYASH on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,038 Cr vs ₹2,445 Cr
P/E Ratio
SOLARA has a lower P/E
-1,492.06x vs 62.48x
P/B Ratio
SOLARA has a lower P/B
1.95x vs 3.81x
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹-1.68
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 41.9%
Qtr Profit Growth
SOLARA has stronger quarterly profit growth
516% vs 455%
ROE
VIYASH has a higher ROE
11% vs -0.13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSOLARAVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricSOLARAVIYASH
Live Price₹507₹253.45
Day Change0.4%-2.41%
Volume1.94 L9.28 L
52-Week High₹712₹298
52-Week Low₹422₹178.13
Distance from 52W High-28.79%-14.95%

Valuation

MetricSOLARAVIYASH
Market Cap₹2,445 Cr₹11,038 Cr
P/E Ratio-1,492.06x62.48x
P/B Ratio1.95x3.81x
EPS₹-1.68₹4.06
Book Value₹287.12₹66.6
Dividend Yield0%0%

Growth

MetricSOLARAVIYASH
Revenue Growth (TTM YoY)41.9%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth41.9%129%
Qtr Profit Growth516%455%

Profitability & Leverage

MetricSOLARAVIYASH
ROE-0.13%11%
ROCE4.86%19%
Net Margin-0.54%6.57%
Operating Margin13.6%19.1%
Debt to Equity0.55x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSOLARAVIYASH
Promoter Holding41.93% 0.07 pp0%
FII Holding11.52% 0.19 pp4.5% 1.56 pp
DII Holding3.74% 0.04 pp3.75% 4.24 pp
Public Holding42.81% 0.08 pp30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Solara Active Pharma Sciences Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.